“…Mammalian Sfrp1 is also strongly expressed in embryonic myocardium, differentiated heart muscle and cardiomyocytes, and, as in Xenopus, expression is specifically excluded from the pericardium (Jaspard et al, 2000). Remarkably, Sfrp1 is transiently upregulated in a mouse model following experimentally induced myocardial infarction, predominantly at the infarct border zone, and, moreover, transgenic overexpression of Sfrp1 in the mouse model resulted in reduced infarct size and improved recovery (Barandon et al, 2003), which has since been found to be part of a coordinated response to myocardial infarction that also involves increased neovascularisation and reduced inflammatory response and scar formation (Barandon et al, 2011). During early mammalian heart development, Sfrp1 appears to function at least partially redundantly with other factors (Trevant et al, 2008), specifically Sfrp2, which, however, also mediates prominent Wnt-independent functions in the heart (Kobayashi et al, 2009).…”